$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of domestic pricing and medical insurance coverage of Daridorexant
2026-02-01 22:25:32
Check Details
Comparative analysis of the characteristics of olaparib (lipadro) targeted drug and chemotherapy drugs
2026-02-01 22:25:32
Check Details
Analysis of indications and clinical application population of Venetoclax/Venetoclax (Vekela)
2026-02-01 22:25:32
Check Details
Detailed instructions and medication instructions for Asnib/Assiminib (Xinbeli)
2026-02-01 22:25:32
Check Details
Analysis of the therapeutic effect of ritexitinib (Lefenox) on vitiligo and patient feedback
2026-02-01 22:25:32
Check Details
How long do side effects of Ixazomib (Enleri) usually last and how to relieve them?
2026-02-01 22:25:32
Check Details
How many tubes of rubitin/rubicatin (Zanbega) are usually needed at one time and dosage recommendations
2026-02-01 22:25:32
Check Details
Analysis of the standard dosage and usage of ensifentrine-Ohtuvayre and patient medication precautions
2026-02-01 22:25:32
Check Details
Detailed instructions on the correct method and timing of taking Roaccutane (isotretinoin) soft capsules
2026-02-01 22:25:32
Check Details
Is Doxorubicin the same as doxorubicin? Comparative analysis of similarities, differences and clinical applications between the two
2026-02-01 22:25:32
Check Details
Is Everolimus covered by medical insurance? Analysis of medical insurance policy and reimbursement process
2026-02-01 22:25:32
Check Details
The maximum taking time and dosage limit of estramustine phosphate (Adelox) in a month
2026-02-01 22:25:32
Check Details
1
2
...
2150
2151
2152
2153
2154
2155
2156
...
10227
10228
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
2
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
3
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
4
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
5
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
6
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
7
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
8
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
9
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
10
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
11
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
12
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection